Article
A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI Level and activated partial thromboplastin time.
Arteriosclerosis, thrombosis, and vascular biology - 1 Aug 2012
Sabater-Lleal Maria, Martinez-Perez Angel, Buil Alfonso, Folkersen Lasse, Souto Juan Carlos, Bruzelius Maria, Borrell Montserrat, Odeberg Jacob, Silveira Angela, Eriksson Per, Almasy Laura, Hamsten Anders, Soria José Manuel
Abstract excerpt
OBJECTIVE: Elevated plasma levels of coagulation factor XI (FXI) are implicated in the pathogenesis of venous thromboembolism and ischemic stroke, and polymorphisms in the F11 gene are associated both with risk of venous thromboembolism and an elevated plasma FXI level. METHODS AND RESULTS: Here, we report the first hypothesis-free genome-wide genetic analysis of plasma FXI levels. Two genome-wide significant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
